Gene for manic depression
Key points
- Scientists have identified a gene mutation that causes manic depression in as many as one in 10 patients.
- The findings are based on an analysis of DNA samples from more than 400 families.
- The gene, GRK3, plays an important role in regulating the way the brain responds to chemicals such as dopamine which are known to control mood.
- The mutation, discovered by a team from the University of California, San Diego, occurs in the gene's on-off switch.
Scientists have identified a gene mutation that causes manic depression in as many as one in 10 patients.
The gene, GRK3, plays an important role in regulating the way the brain responds to chemicals such as dopamine which are known to control mood.
The mutation, discovered by a team from the University of California, San Diego, occurs in the gene's on-off switch.
This may mean that the gene is activated inappropriately, or turned off when it should be working.
The researchers believe the mutation causes those who carry it to become hypersensitive to dopamine - leading to extremes of mood.
Manic depression, known technically as bipolar disorder, is a complex condition.
Patients veer between barely-controlled euphoria and feeling very down.
Drug therapies are available, but doctors estimate that they have little effect on up to half of patients.
Researcher Dr John Kelsoe said: "Our hope is that discovery of genetic defects that cause bipolar disorder will lead to new drugs that can be directed to those specific genes."
Extensive analysis
The findings are based on an analysis of DNA samples from more than 400 families.
Dr Kelsoe said: "We believe that a defect in GRK3 may make one super-sensitive to dopamine, somewhat like being born on cocaine."
Amanda Harris, of the charity Manic Depression Fellowship, told BBC News Online that better ways to diagnose manic depression, and better treatments were badly needed.
She said it could take 10 years for the condition to be diagnosed.
"Manic depression probably has several underpinning reasons, and at the moment treatment is very hit and miss," she said.
The research is published in the journal Molecular Psychiatry.
Content provided by ArmMed Media
Revision date: 12 December 2007
Last revised by Amalia K. Gagarina, M.S., R.D.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Mental Health →
NewsGene study points towards therapies for common brain disorders
Scientists have pinpointed the cells that are likely to trigger common brain disorders, including Alzheimer's disease, Multiple Sclerosis and intellectual disabilities. It is the first time researchers have been able to…
29 January 2016
NewsDiagnosing depression before it starts
A new brain imaging study from MIT and Harvard Medical School may lead to a screen that could identify children at high risk of developing depression later in life. In the study, the researchers found distinctive brain…
22 January 2016
NewsScientists isolate genes that delay Alzheimer'
Scientists have identified a network of nine genes that play a key role in the onset of Alzheimer's Disease. The finding could help scientists develop new treatments to delay the onset of the disease, said lead…
2 December 2015
